Trademark: 97682923
Word
NEXT SUMMIT DX
Status
Pending
Status Code
688
Status Date
Tuesday, January 23, 2024
Serial Number
97682923
Mark Type
4000
Filing Date
Thursday, November 17, 2022
Published for Opposition
Tuesday, November 28, 2023

Trademark Owner History
Personalis, Inc. - Owner At Publication

Classifications
44 Analysis of cells, tissues, gene expressions, gene sequences, genome annotation, transcriptome characterization, and genome mapping for medical diagnosis and treatment; Preparation of reports relating to gene expressions, gene and genome sequences, genome interaction and annotation, transcriptome analysis and characterization, and genome mapping for medical diagnosis and treatment
42 Providing genome sequencing, data analysis and interpretation, assay development and preparing, amplifying, labeling, detecting, analyzing and sequencing nucleic acids and other biological molecules, and research and design relating thereto, all in the field of bioinformatics, genomics and gene expression research and development
"DX"

Trademark Events
Jan 23, 2024
Noa E-Mailed - Sou Required From Applicant
Nov 28, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 28, 2023
Published For Opposition
Nov 8, 2023
Notification Of Notice Of Publication E-Mailed
Oct 26, 2023
Approved For Pub - Principal Register
Oct 25, 2023
Teas/Email Correspondence Entered
Oct 25, 2023
Correspondence Received In Law Office
Oct 25, 2023
Teas Response To Office Action Received
Jul 25, 2023
Notification Of Non-Final Action E-Mailed
Jul 25, 2023
Non-Final Action E-Mailed
Jul 25, 2023
Non-Final Action Written
Jul 18, 2023
Assigned To Examiner
Dec 8, 2022
New Application Office Supplied Data Entered
Nov 21, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24